Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | английский |
| Опубликовано: |
2019
|
| Online-ссылка: | https://doi.org/10.1183/23120541.00056-2019 https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|